Domestic pharmaceutical industry likely to lose momentum over rebate ban

Korean firms’ generic drugs are expected to lose steam once the government cracks down on pharmaceutical firms offering rebates starting August.

Experts said domestic manufacturers can no longer expect to live off of selling copied drugs, as hospitals will probably choose to prescribe originals over generics without kickbacks.

Under the new regulations, the government will be allowed to f...